Evaluation of heliox efficacy in acute asthma attack

Phase 3

• Conditions: Acute attack asthma.; Asthma

• Registration Number: IRCT2015100715446N6
• Lead Sponsor: Vice chanceller for research,Ahvaz Jundishapur University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 96

Inclusion Criteria

Inclusion Criteria: Acute Asthma Attack with minimum of 18 years old and maximum of 55year;

Exclusion Criteria

History of Smoking more than 10 pack/ years; History of chronic bronchitis; acute medical problem; History of Cardiovascular Diseases;cardiac arythmia; Pregnant women; treatment with nebulization of beta agonist during 6 hours ago.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Clinical state. Timepoint: Before intervention 20,40,60 minutes after intervention. Method of measurement: Base on alert status,talking,wizing,use of respiratory muscles.;Forced Expiratory Volum in First Second (FEV1). Timepoint: Before intervention 20,40,60 minutes after intervention. Method of measurement: Mililiter with use of Peak Flow Meter.;Peak Expiratory Flow Rate(PEFR). Timepoint: Before intervention 20,40,60 minutes after intervention. Method of measurement: Mililiter with use of Peak Flow Meter.

Secondary Outcome Measures

Name	Time	Method
Blood pressure. Timepoint: Before intervention 20,40,60 minutes after intervention. Method of measurement: mm Hg.;Pulse Rate. Timepoint: Before intervention 20,40,60 minutes after intervention. Method of measurement: Rate/Minutes.;Respiratory Rate. Timepoint: Before intervention 20,40,60 minutes after intervention. Method of measurement: Rate/Minutes.;Saturation of arterial blood oxygen (SO2 %). Timepoint: Before intervention 20,40,60 minutes after intervention. Method of measurement: with Pulse Oximetry.;Pulsus Paradox. Timepoint: Before intervention 20,40,60 minutes after intervention. Method of measurement: 10 reduse of Blood Pressure during inspiration.